Hans Herweijer

3.4k total citations
39 papers, 2.7k citations indexed

About

Hans Herweijer is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hans Herweijer has authored 39 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 19 papers in Genetics and 14 papers in Oncology. Recurrent topics in Hans Herweijer's work include Virus-based gene therapy research (17 papers), RNA Interference and Gene Delivery (17 papers) and Drug Transport and Resistance Mechanisms (9 papers). Hans Herweijer is often cited by papers focused on Virus-based gene therapy research (17 papers), RNA Interference and Gene Delivery (17 papers) and Drug Transport and Resistance Mechanisms (9 papers). Hans Herweijer collaborates with scholars based in United States, Netherlands and France. Hans Herweijer's co-authors include Jon A. Wolff, Kees Nooter, David L. Lewis, James E. Hagstrom, A. G. Loomis, Guofeng Zhang, Pieter Sonneveld, Frank Baas, Jeffery D. Fritz and Vladimir G. Budker and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Blood.

In The Last Decade

Hans Herweijer

39 papers receiving 2.6k citations

Peers

Countries citing papers authored by Hans Herweijer

Since Specialization

Citations

This map shows the geographic impact of Hans Herweijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Herweijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Herweijer more than expected).

Fields of papers citing papers by Hans Herweijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Herweijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Herweijer. The network helps show where Hans Herweijer may publish in the future.

Co-authorship network of co-authors of Hans Herweijer

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Herweijer. A scholar is included among the top collaborators of Hans Herweijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Herweijer. Hans Herweijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustained liver‐specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery 2008 ·The Journal of Gene Medicine ·Christine I. Wooddell, (unknown), Jon A. Wolff, Hans Herweijer	57
2	Rapidly Reversible Hydrophobization: An Approach to High First-Pass Drug Extraction 2007 ·Chemistry & Biology ·Sean Monahan, (unknown), Vladimir G. Budker, (unknown), Zane C. Neal, Hans Herweijer, Jon A. Wolff	6
3	Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice 2006 ·Nucleic Acids Research ·Angus T. De Souza, Xudong Dai, Andrew Spencer, (unknown), (unknown), P. Roesch, Yudong D. He, (unknown), (unknown), Hans Herweijer, Jon A. Wolff, James E. Hagstrom, David L. Lewis, Peter S. Linsley, Roger G. Ulrich	90
4	Long-term RNA interference from optimized siRNA expression constructs in adult mice 2005 ·Biochemical and Biophysical Research Communications ·Christine I. Wooddell, Cristopher V. Van Hout, (unknown), David L. Lewis, Hans Herweijer	23
5	Nonviral Vectors for Cardiovascular Gene Delivery 2003 ·PubMed ·Jon A. Wolff, Hans Herweijer	4
6	Time course of gene expression after plasmid DNA gene transfer to the liver 2001 ·The Journal of Gene Medicine ·Hans Herweijer, Guofeng Zhang, Владимир Субботин, Vladimir G. Budker, Phillip Williams, Jon A. Wolff	120
7	Combined radiation and p53 gene therapy of malignant glioma cells 1999 ·Cancer Gene Therapy ·Behnam Badie, (unknown), (unknown), Hans Herweijer, David A. Boothman	71
8	Reciprocal Enhancement of Gene Transfer by Combinatorial Adenovirus Transduction and Plasmid DNA Transfection in Vitro and in Vivo 1999 ·Human Gene Therapy ·Edward J. Dunphy, Rebecca Redman, Hans Herweijer, Timothy P. Cripe	22
9	Gene Transfer into Mammalian Cells Using Histone-Condensed Plasmid DNA 1996 ·Human Gene Therapy ·Jeffery D. Fritz, Hans Herweijer, Guofeng Zhang, Jon A. Wolff	123
10	A Plasmid-Based Self-Amplifying Sindbis Virus Vector 1995 ·Human Gene Therapy ·Hans Herweijer, (unknown), Phillip Williams, Guofeng Zhang, István Dankó, Sondra Schlesinger, Jon A. Wolff	76
11	Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection 1993 ·Human Molecular Genetics ·István Dankó, Jeffery D. Fritz, (unknown), Hans Herweijer, Edward Schultz, Jon A. Wolff	55
12	A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance 1991 ·British Journal of Cancer ·Jaap Verweij, Hans Herweijer, R. Oosterom, (unknown), A.S.T. Planting, Caroline Seynaeve, G. Stoter, Kees Nooter	59
13	Multidrug resistance (mdr) genes in human cancer 1991 ·British Journal of Cancer ·Kees Nooter, Hans Herweijer	178
14	Overexpression of the MDRL gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin‐A 1990 ·International Journal of Cancer ·Kees Nooter, Pieter Sonneveld, Robert Oostrum, Hans Herweijer, (unknown), Dinko Valerio	113
15	Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by Cyclosporine 1990 ·JNCI Journal of the National Cancer Institute ·Hans Herweijer, Pieter Sonneveld, Frank Baas, Kees Nooter	187
16	Expression of the mdr3 gene in prolymphocytic leukemia: Association with cyclosporin‐a‐induced increase in drug accumulation 1990 ·International Journal of Cancer ·Kees Nooter, Pieter Sonneveld, (unknown), Robert Oostrum, (unknown), Hans Herweijer, (unknown), Anne Hagemeijer, Frank Baas	51
17	The use of E. coli exonuclease III to generate single stranded DNA in BrdUrd cell-cycle analysis permits simultaneous detection of cell surface antigens 1990 ·Journal of Immunological Methods ·Jan Bayer, Peter de Vries, Hans Herweijer, J. G. J. Bauman	10
18	Effects of cyclosporin a and verapamil on the intracellular daunorubicin accumulation in chinese hamster ovary cells with increasing levels of drug‐resistance 1989 ·International Journal of Cancer ·(unknown), Antonius W.M. Boersma, (unknown), Rik J. Scheper, Hans Herweijer, Kees Nooter	30
19	A rapid and sensitive flow cytometric method for the detection of multidrug‐resistant cells 1989 ·Cytometry ·Hans Herweijer, Ger van den Engh, Kees Nooter	36
20	High‐speed photodamage cell selection using bromodeoxyuridine/Hoechst 33342 photosensitized cell killing 1988 ·Cytometry ·Hans Herweijer, (unknown), Jan Visser	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact